Sensus Healthcare director buys 1,500 shares as Q1 revenue plunges 59%
Director Sachetta Eric purchased 1,500 shares, raising his stake to 143,613 shares. Sensus Healthcare’s Q1 revenue fell from $8.3 million to $3.4 million due to the loss of its largest customer and CPT code transition, though initial reimbursement results are positive and a commercial dispute was resolved.
1. Insider Share Purchase
Director Sachetta Eric purchased 1,500 shares, raising his total holdings to 143,613 shares, reflecting confidence in Sensus Healthcare’s prospects.
2. Q1 Financial Performance
The company reported Q1 2026 revenue of $3.4 million, down 59% from $8.3 million in Q1 2025, primarily due to the absence of its largest historical customer.
3. CPT Code Transition and Dispute Resolution
New dedicated CPT codes for superficial radiotherapy became effective January 1, 2026, and early reimbursement feedback is positive. Sensus Healthcare also resolved a commercial dispute with SkinCure Oncology, allowing renewed focus on its growth strategy.